Saturday 17 October 2026
Export DXCM’s income statement to Excel — free account
DexCom, Inc.
DXCM Healthcare Medical Devices
DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue grew 13.1%, EPS grew 41.3%, free cash flow fell 11.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
86.06
1.65
−1.88%
Follow DXCM
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
8 | 5 | 7 | 6 | 5 | 5 | 5 | 3 | 5 | 3 |
P/E ratio |
30.87 | 52.90 | 87.30 | 130.38 | 281.07 | 71.65 | 200.70 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
6.43 | 5.72 | 8.52 | 9.43 | 12.21 | 9.90 | 9.12 | 5.62 | 6.53 | 24.43 |
P/S ratio |
5.56 | 7.59 | 13.12 | 15.35 | 21.21 | 18.11 | 13.50 | 10.24 | 6.97 | 8.49 |
P/FCF ratio |
24.04 | 48.53 | 92.82 | 146.62 | 19.10 | 126.15 | 148.17 | 188.35 | 192.52 | 9,737.73 |
Altman Z″-Score (non-manufacturers) |
4.98 | 3.31 | 4.70 | 3.69 | 5.14 | 5.39 | 4.47 | 3.60 | 2.57 | (0.70) |
P/Operating CF |
88.09 | 101.56 | 355.63 | 337.18 | 490.90 | 202.86 | 138.69 | 313.54 | 121.49 | 366.08 |
Beneish M-Score |
(2.70) | (2.67) | (2.39) | (2.29) | (2.49) | (1.60) | (1.95) | (2.54) | (3.45) | (3.29) |
P/B ratio |
9.43 | 14.56 | 22.97 | 20.96 | 25.43 | 19.10 | 22.58 | 15.93 | 11.93 | 17.16 |
Price to Tangible BV |
9.77 | 15.49 | 24.89 | 23.11 | 26.18 | 19.54 | 23.07 | 16.39 | 12.29 | 17.87 |
EV/Sales |
5.56 | 7.45 | 13.25 | 15.19 | 20.92 | 17.58 | 13.19 | 9.88 | 6.66 | 8.28 |
EV/EBITDA |
22.27 | 36.74 | 61.24 | 80.77 | 139.25 | 92.39 | 101.93 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
17.99 | 30.36 | 64.12 | 66.00 | 115.74 | 71.21 | 61.91 | 82.73 | 52.02 | 84.47 |
EV/FCF |
24.06 | 47.63 | 93.76 | 145.03 | 18.83 | 122.45 | 144.75 | 181.69 | 184.08 | 9,494.53 |
Quick Ratio |
1.50 | 1.22 | 2.38 | 1.72 | 4.50 | 5.11 | 5.05 | 7.25 | 4.92 | 2.20 |
Current Ratio |
1.88 | 1.47 | 2.84 | 1.99 | 5.11 | 5.58 | 5.47 | 7.64 | 5.36 | 2.73 |
Net Debt/EBITDA |
(0.65) | (1.64) | (0.37) | (0.89) | (1.98) | (2.79) | (2.41) | 2.39 | 8.37 | 2.41 |
Debt/Assets |
19.57% | 19.08% | 38.86% | 36.54% | 40.60% | 39.25% | 44.83% | 52.73% | 36.23% | 1.49% |
Debt/Equity |
0.45 | 0.59 | 1.18 | 0.92 | 0.98 | 0.92 | 1.22 | 1.52 | 0.78 | 0.02 |
Asset Turnover |
0.73 | 0.63 | 0.62 | 0.56 | 0.53 | 0.58 | 0.68 | 0.73 | 1.10 | 1.65 |
Operating CF/Net income |
1.72 | 1.72 | 1.38 | 1.96 | 2.04 | 0.87 | 3.11 | (0.97) | (1.83) | (0.86) |
Capex/Depreciation |
(1.44) | (1.65) | (1.27) | (2.34) | 22.32 | (2.97) | (3.70) | (2.31) | (4.10) | (3.71) |
Interest Coverage |
— | — | — | 21.03 | 14.14 | 16.92 | 2.36 | (8.21) | (3.32) | (91.29) |
| 34.50% | 27.63% | 25.78% | 16.35% | 11.21% | 40.58% | 13.08% | (23.48%) | (14.28%) | (25.98%) | |
| 13.04% | 9.04% | 9.29% | 6.61% | 4.70% | 16.44% | 4.69% | (9.01%) | (7.68%) | (18.88%) | |
ROIC |
28.66% | 49.33% | 21.00% | 14.86% | 12.65% | 23.31% | 21.03% | (40.43%) | (13.39%) | (24.04%) |
Return on Tangible Assets |
24.24% | 21.27% | 13.60% | 11.83% | 5.76% | 16.53% | 5.24% | (7.66%) | (6.68%) | (22.86%) |
Average Days of Receivables |
95.21 | 91.02 | 98.13 | 89.48 | 76.67 | 81.18 | 70.80 | 80.21 | 68.22 | 64.75 |
Research and Development Expense of Revenue |
12.85% | 13.70% | 13.96% | 16.64% | 24.68% | 18.68% | 18.53% | 40.46% | 25.80% | 27.23% |
Selling, General and Administrative Expense of Revenue |
27.69% | 31.88% | 32.73% | 34.63% | 33.10% | 32.09% | 34.94% | 41.95% | 48.60% | 49.92% |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.03 | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 |
Share Based Compensation of Revenue |
3.42% | 4.23% | 4.16% | 4.35% | 4.63% | 6.20% | 6.96% | 9.88% | 14.78% | 19.33% |
Graham Net Nets |
0.02 | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 | 0.02 | 0.04 | 0.05 | 0.03 |
Graham Number |
18.45 | 13.29 | 13.04 | 10.41 | 7.53 | 11.85 | 3.85 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
3.24% | 1.89% | 1.15% | 0.77% | 0.36% | 1.40% | 0.50% | (1.20%) | (1.02%) | (1.34%) |
Free Cash Flow Yield |
4.16% | 2.06% | 1.08% | 0.68% | 5.24% | 0.79% | 0.67% | 0.53% | 0.52% | 0.01% |
Revenue per Share |
11.95 | 10.25 | 9.38 | 7.47 | 6.33 | 5.10 | 4.05 | 2.92 | 2.08 | 1.71 |
Operating CF per Share |
3.69 | 2.51 | 1.94 | 1.72 | 1.14 | 1.26 | 0.86 | 0.35 | 0.27 | 0.17 |
Capex per Share |
(0.93) | (0.91) | (0.61) | (0.94) | 5.89 | (0.53) | (0.49) | (0.19) | (0.19) | (0.17) |
Free Cash Flow per Share |
2.76 | 1.60 | 1.33 | 0.78 | 7.03 | 0.73 | 0.37 | 0.16 | 0.08 | 0.00 |
Cash per Share |
5.12 | 6.55 | 7.06 | 6.31 | 7.06 | 7.17 | 4.21 | 3.93 | 1.59 | 0.37 |
Shareholders Equity per Share |
7.04 | 5.34 | 5.36 | 5.47 | 5.28 | 4.84 | 2.42 | 1.88 | 1.21 | 0.85 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.04 | 5.34 | 5.36 | 5.47 | 5.28 | 4.84 | 2.42 | 1.88 | 1.21 | 0.85 |
Free Cash Flow |
1,077.20 | 630.70 | 511.90 | 304.70 | 2,719.60 | 276.60 | 134.50 | 56.10 | 26.00 | 0.50 |
Working Capital |
1,890.80 | 1,369.40 | 2,869.90 | 1,829.50 | 2,963.60 | 2,810.70 | 1,609.20 | 1,477.10 | 605.80 | 177.60 |
Capital Expenditures |
(363.50) | (358.80) | (236.60) | (364.80) | 2,277.10 | (199.00) | (180.00) | (67.10) | (66.00) | (55.70) |
Net Current Asset Value |
439.40 | (80.50) | 230.00 | 408.90 | 793.20 | 960.80 | 457.00 | 446.80 | 260.00 | 161.00 |
EV/EBIT |
28.42 | 50.07 | 80.30 | 112.96 | 192.68 | 113.08 | 136.82 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.08 | 0.09 | 0.07 | 0.13 | (0.93) | 0.10 | 0.12 | 0.07 | 0.09 | 0.10 |
Price to Operating Income |
28.40 | 51.02 | 79.49 | 114.20 | 195.40 | 116.50 | 140.05 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.16 | 0.16 | 0.17 | 0.15 | 0.13 | 0.13 | 0.15 | 0.16 | 0.11 | 0.14 |
Cash ROIC |
18.00% | 10.66% | 7.08% | 4.65% | 40.14% | 4.45% | 3.85% | 1.83% | 2.01% | 0.12% |
Accounts Receivable Turnover |
4.20 | 4.07 | 4.29 | 4.74 | 5.19 | 5.39 | 5.75 | 5.72 | 6.09 | 6.52 |
Accounts Payable Turnover |
1.05 | 1.09 | 1.19 | 1.39 | 1.46 | 1.75 | 2.70 | 3.14 | 2.92 | 3.64 |
Inventory Turnover |
3.18 | 2.89 | 3.08 | 3.09 | 2.59 | 3.65 | 5.72 | 6.35 | 5.00 | 4.84 |
Average Days of Payables |
381.46 | 362.78 | 368.31 | 320.60 | 272.32 | 271.58 | 171.88 | 146.02 | 140.58 | 127.53 |
Days of Inventory on Hand |
123.45 | 124.18 | 153.18 | 109.03 | 169.81 | 132.49 | 80.31 | 70.18 | 72.87 | 85.02 |
Average Receivables |
1,110.90 | 989.80 | 843.60 | 613.80 | 471.40 | 357.40 | 256.50 | 180.50 | 118.00 | 87.90 |
Average Payables |
1,764.55 | 1,465.30 | 1,123.65 | 737.40 | 527.05 | 368.75 | 201.75 | 117.15 | 77.65 | 53.50 |
Average Inventory |
585.85 | 551.10 | 433.15 | 332.00 | 296.00 | 177.25 | 95.25 | 57.95 | 45.30 | 40.30 |
Average Assets |
6,412.20 | 6,374.50 | 5,828.10 | 5,162.50 | 4,611.90 | 3,342.75 | 2,155.50 | 1,410.05 | 653.45 | 347.40 |
Average Common Equity |
2,424.30 | 2,085.60 | 2,100.20 | 2,086.95 | 1,934.30 | 1,354.55 | 772.95 | 541.35 | 351.60 | 252.50 |
Columns are period end dates